Investment
Pioneer Group Leads $2.34m Investment In Neobe Therapeutics’ Cancer Therapy Innovation
Steve Jarvis2024-11-28T14:25:26+00:00February 29th, 2024|
Neobe Therapeutics, a pioneering synthetic biology startup at the forefront ...
BioCity Glasgow: BioAscent Invests In New State-Of-The-Art Protein Production Facility
Steve Jarvis2024-11-28T14:25:44+00:00February 23rd, 2024|
Integrated drug discovery services provider BioAscent - based at Pioneer ...
IsomAb Closes £7.5m Financing To Drive New Diabetic Treatment
Steve Jarvis2024-11-28T14:26:00+00:00February 21st, 2024|
BioCity Nottingham's IsomAb, a University of Nottingham spin-out pioneering a ...
Accelerator
Pioneer Group Appointed Delivery Partner For Innovate UK’s Biomedical Catalyst Accelerator Programme
Amy Cotterill2024-11-28T14:45:08+00:00May 10th, 2023|
We are delighted to have been selected as a neurotechnology ...
Life Science Accelerator Programme: How Cutting-Edge Companies Are Growing Organically At BioCity Nottingham
Amy Cotterill2024-11-28T14:46:11+00:00April 17th, 2023|
Pioneer Group’s life science Accelerator Programme provides science entrepreneurs with ...
NanoSyrinx Joins Life Sciences Incubator In Nottingham
Amy Cotterill2024-11-28T14:47:44+00:00March 27th, 2023|
Pioneer Group would like to officially welcome NanoSyrinx to our ...